Cargando…
Olanzapine-induced Neuroleptic Malignant Syndrome
Neuroleptic malignant syndrome (NMS) is a life-threatening adverse effect usually seen with typical antipsychotic drugs. Rarely, NMS can occur with atypical antipsychotics also. A 19-year-old male diagnosed as a case of acute and transient psychotic disorder developed NMS, following the treatment wi...
Autores principales: | Saha, Pradeep Kumar, Chakraborty, Abhijit, Layek, Avik Kumar, Chakraborty, Aritra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461854/ https://www.ncbi.nlm.nih.gov/pubmed/28615778 http://dx.doi.org/10.4103/0253-7176.207320 |
Ejemplares similares
-
Olanzapine-Induced Neuroleptic Malignant Syndrome
por: Hosseini, Seyedhamze, et al.
Publicado: (2017) -
Olanzapine induced neuroleptic malignant syndrome
por: Patra, Bichitra Nanda, et al.
Publicado: (2013) -
Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
por: Sahoo, Manoj Kumar, et al.
Publicado: (2017) -
A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period
por: Üstündağ, Mehmet, et al.
Publicado: (2007) -
Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome with Rhabdomyolysis: A Case Report
por: Sa, Young Kyoung, et al.
Publicado: (2013)